None listed
Conditions
Brief summary
Study hypothesis is that a doctor-pharmacist collaborative prescribing model provides at least as high a quality of care as usual care with regards to safety, access, appropriateness, effectiveness, efficiency and consumer participation
Interventions
The pharmacist in pre-admission clinic will generate the inpatient medication chart to reflect the patient's regular medication, plan for medication peri-operatively and also prescribe venous thromboembolism (VTE) prophylaxis in clinic according to agreed local and national guidelines.
The intervention will occur on a daily basis for a number of patients attending pre-admission clinic, and will run for approximately 6 months or until 360 patients are recruited.
Sponsors
Medication Services Queensland
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Elective surgical patients attending pre-admission clinic. Minimum age 18 Maximum age no limit
Exclusion criteria
Exclusions include people whose primary language is other than English, patients unwilling or unable to provide informed consent, patients who have their surgery cancelled on the day of pre-admission clinic, day surgery patients, cardio-thoracic surgery patients and any patients under the care of units that do not have agreed guidelines for VTE prophylaxis
Outcome results
None listed